Synapse - Joachim Yahalom

Results (96)

Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047

Meeting Abstract

Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
Blood (2008)

Fulltext@MSK | Save

Pre-transplant evaluation with both CT and PET following second-line therapy is essential for predicting outcome in patients with transplant-eligible relapsed and primary refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A. J.; Nimer, S. D.; Zelenetz, A. D.; Kewalramani, T.; Vanak, J. M.; Maragulia, J. C.; Yahalom, J.; Moskowitz, C.
Blood (2008)

Fulltext@MSK | Save

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A.; Yahalom, J.; Kewalramani, T.; Tejerina, M.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save

Relapsed and primary refractory diffuse large B-Cell lymphoma: Improving outcome by incorporating involved field radiotherapy into a comprehensive second-line high-dose therapy strategy

Meeting Abstract

Hoppe, B. S.; Yahalom, J.; Kewalramani, T.; Hamlin, P. A.; Rice, D.; Filippa, D.; Maragulia, J.; Weaver, A.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save

Relapsed and refractory primary mediastinal diffuse large B-cell lymphoma: Outcome with ICE-based treatment

Meeting Abstract

Hamlin, P. A.; Dickson, M.; Kewalramani, T.; Horwitz, S. M.; Portlock, C. S.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2006)

Fulltext@MSK | Save

High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma

Meeting Abstract

Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
Blood (2005)

Fulltext@MSK | Save

The utility of consolidative upfront high dose chemoradiotherapy and ASCT in patients with mantle cell lymphoma (MCL)

Meeting Abstract

Persky, Daniel; Portlock, Carol S.; Lessac-Chenen, Simone; Iasonos, Alexia; Zelenetz, Andrew D; Kewalramani, Tarun; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Moskowitz, Craig H.
Blood (2005)

Fulltext@MSK | Save

Primary Mediastinal Large B cell Lymphoma: Elucidating optimal therapy and prognostic factors; an analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980-1999

Meeting Abstract

Hamlin, P. A.; Portlock, C. S.; Straus, D. J.; Noy, A.; Horwitz, S. M.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2004)

Fulltext@MSK | Save

Bronchial-associated lymphoid tissue (BALT) lymphoma: Characteristics and treatment outcome of 19 cases

Meeting Abstract

Beal, K. P.; Portlock, C.; Yahalom, J.
Blood (2004)

Fulltext@MSK | Save

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

Journal Article

Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
Blood (2004)

Fulltext@MSK | Save